Guadecitabine is a decitabine analogue with efficacy in MDS. In this phase II, single-arm trial, PTCL patients received guadecitabine on days 1-5 of 28-day cycles.
Domain | guadecitabinechemical.com |
---|---|
Homepage URL | https://guadecitabinechemical.com/a-survey-involving-inner-treatments-interns-about-the-very-useful/ |
Keywords | guadecitabine chemical iap modulator algal biotechnology |
Sprache | englisch |